It is a salt of an aromatic fatty acid, 4-phenylbutyrate (4-PBA) or 4-phenylbutyric acid. Our in-depth knowledge and industrial expertise has enabled us to emerge as a reputed organization engaged in offering Sodium Phenylbutyrate. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. Sodium Phenylbutyrate also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the γ-globin gene. It is used for the management of chronic urea cycle disorders due to deficiencies in carbamylphosphate.